A Natural Environmental Health Facts Ezine

`````````````````````````````````````````````````````
"A NATURAL ENVIRONMENTAL HEALTH FACTS Ezine" Here to Inform and Help You Become Healthier and Happier while Achieving Quality Longevity!

http://www.antibiotic-alternatives.com
Email Lena
928-636-9425
Wednesday March 14, 2007
````````````````````````````````````````````````````

Watch for Monday's "Ask Lena Health Q & A edition.
Get Your Health Question Answered Email Click Here
&
Tuesday's & Thursday's "Your Home Business Coach"
The newsletter/ezine for home based businesses and/or find the affiliate of your dreams!

This Ezine is available by subscription only and subscriber requests are kept on file!

I strive to bring you only the most timely, pro's & con's information for the betterment of your health without clogging the issue or your email box with a lot of advertising and other such junk! If I am not
succeeding mailto:health@antibiotic-alternatives.com and let me know!!

Our subscriber list is confidential and we respect your privacy. A N.E.H.F. does not make its list available to third parties. All subscribe and unsubscribe information can be found at the end of this issue.
The Mission of this Ezine Click Here

============================
=> IN THIS ISSUE!
============================

==> Editors' Ranting & or Warnings
==> Something To Think About
==> Health Thought for the day!
==> Showcase Health Spotlight
==> Monthly Spotlight Ads
==> Today's Health Tip
==> Health Today
==> Environmental Report
==> Life Changing Information

Greetings and thank you for being an optin subscriber!

I truly wish I could pass on some really good and positive information on the betterment of Traditional medicine but that just can't happen with the things going on within that world today... Just as Mother Nature is confused so is the medical world as the pharmaceutical industry continues to confuse them and give them false hope and erroneous information! Today's issue points out some of that confusing information!

Summer before its time! Last week snow this week summer weather. Our fruit trees are blooming after only a few days of warmth, just right for killing when we get the frost and/or freeze that is sure to come sometime in the next few weeks. Unless global warming has really switched our seasons to opposite of norm and summer has been extended big time... Ordinarily here in the mountains we have winter weather up to the end of May and sometimes into June... Means no fruit for us this year... Mother Nature is so confused she can't figure out what type of weather to have from one day to the next... Well all you can do is make sure your immune system is in top shape to try and escape the onslaught of allergies and colds that are sure to come into play with these changes...

ANEH Facts archives Click Here
Ask Lena Health Q & A Archives Click Here
Your Home Business Coach Archives Click Here

==> Find An Alternative Health Professional
==>Latest Product Recalls - I'm appalled at the number of things, particularly medications, recalled weekly/daily neither your doctor nor your news stations are telling you about, so how are you going to know? Look here for DAILY Product Recall Site
===> Help The World Without Spending!
http://www.unicefusa.org/emergencies/
===>Help Feed The Hungry Doesn't Cost You A Penny
http://www.thehungersite.com Share your LOVE here!

==================================
Something To Think About
============================

In the past twenty years medical research in this country has increasingly come to rely on the financial support of the pharmaceutical industry - to such an extent, in fact, that industry backing is now considerably larger than that provided by the National Institutes of Health.

Recently, a group of researchers at the University of North Carolina set out to determine whether, and to what extent, the financial involvement of the pharmaceutical industry influenced the outcome of clinical research. Published in the journal Cancer last week, their report, which focused specifically on the outcome of breast cancer trials, found that clinical studies backed by the drug industry were much more likely to report a favorable result (Peppercorn 2007). A full 84 percent of industry-backed studies reported positive results, as compared to only 54 percent of those which received no drug company support. And as previous research has repeatedly shown, clinical studies with a positive outcome are far more likely to be published in the medical literature than those with negative findings.

The worth of evidence-based medicine is severely undermined when the evidence on which it is based can be bought in this way. If the medical literature cannot be counted upon for objectivity, how can patients and their caregivers determine which treatments are likely to be of the most benefit? For the newly diagnosed cancer patient, who must quickly make vital decisions based on what is often only a very tenuous understanding of the disease and its treatment, having access to reliable and trustworthy information is of the utmost importance.

~ Ralph Moss PhD, Independent Cancer Researcher

Proven Fact Of Marketing!
Takes a minimum of seven times readings an ad
before the normal buyer will take advantage of your offer...
GET THAT ADVANTAGE HERE!
Spotlight your product or service here!
Ad Information Click Here

======================================
We accept all advertisements in good faith, but the advertisers are completely responsible for the content and accuracy of their advertisements. We do not give any warranties and accept no responsibility. The editor and publisher suggest that you exercise due diligence!
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^

FDA Issues New Warnings on Anemia Drugs
Mar 10, 2007

WASHINGTON (AP) - Federal health officials issued stern new warnings Friday for doctors to more carefully prescribe widely used anemia drugs that can increase the risk of death and other serious problems in patients with cancer and kidney disease.

At issue are drugs sold under the brand names Procrit, Epogen and Aranesp. These drugs are genetically engineered versions of a natural protein, erythropoietin, that increases the number of red blood cells.

Anemia is common with certain forms of kidney disease, especially once a patient is on dialysis, and when cancer patients take chemotherapy.

But the Food and Drug Administration pointed to recent studies that found using too much of the drugs increased the risk of death, blood clots, strokes and heart attacks in patients with chronic kidney failure. In other studies, patients with head and neck cancer had more rapid tumor growth if they used higher-than-recommended doses.

Even when the anemia drugs were used at FDA-recommended doses, giving them to cancer patients not on chemotherapy increased the risk of death, the agency warned. Moreover, some doctors have begun giving the drugs to patients following orthopedic surgery, also increasing the risk of blood clots, FDA said.

Friday, the agency added stern warnings to each of the drug's labels urging that:

_doctors monitor patients' levels of red blood cells and use the lowest possible dose to avoid the need for blood transfusions.

_doctors and patients carefully weigh the risks of using anemia drugs vs. the risk of a transfusion if anemia gets too bad.

Amgen Inc. (AMGN) and Johnson & Johnson (JNJ), companies that manufacture and market the drugs, both said they would work to inform doctors about the new warnings, outlined in a so-called "black box." The warnings are the most serious a drug label can bear.

"Amgen is committed to providing timely and appropriate communications to physicians and patients whenever we become aware of new safety information that could affect clinical practice," said Dr. Roger Perlmutter, Amgen' s executive vice president of research and development.

The FDA also said it would take a new look at how the drugs are marketed, including claims they can improve the quality of life of cancer patients. The Web site for Procrit, for example, says the drug "helps you find the strength you need."

"With the new label being revised today, we will certainly evaluate any marketing claims and revise them as needed," said Stephanie Fagan, a spokeswoman for J&J's Ortho Biotech Products LP.

A panel of FDA advisers is scheduled to discuss the drugs at a May 10 meeting. Their recommendations could lead to further revisions of the drugs' labels, FDA officials said.

In December, lawmakers and some experts raised concerns that Medicare's payment system encouraged overuse of Epogen, endangering patient lives and wasting taxpayer money. FDA officials said they would forward the recent data on the class of drugs to the Centers for Medicare and Medicaid Services.

The three drugs are huge sellers, with combined 2006 U.S. sales of $10 billion, according to IMS Health Inc.

BE A BRAINIAC
GIVE YOUR BRAIN WORKING POWER by taking
Life Transfusion Ionic Liquid Minerals,
MegaNutrient Multifactor vitamins
and Mind Power formula.

~^~^~^~^~^~^~^~^~^~^
HEALTH TODAY
~^~^~^~^~^~^~^~^~^~^~

Growing Controversy Over New Merck Vaccines

Gardasil, Zostavax, and Rotateq were all vaccines introduced by Merck in late 2005 in an attempt to turn their finances around in the wake of litigation over thousands of deaths allegedly caused by the painkiller Vioxx.

However, Gardasil has caused conflicts between state legislatures who want to require young girls to take it and parents who believe such laws circumvent their rights. Meanwhile, Rotateq, designed to prevent gastrointestinal illnesses in children, has led to growing incidents of intussusception, a rare and life-threatening form of intestinal blockage.

In the wake of the continuing controversy over the Gardasil human papillomavirus (HPV) vaccine, Merck has ended its lobbying campaign to make Gardasil a mandatory vaccine in the United States. The American Academy of Pediatrics, which has been supportive of Gardasil, was nonetheless pleased about the end of the campaign, citing concerns about requiring another vaccine for a problem that doesn't have a large impact on health nationwide.
At the same time, reports are being made of side effects associated with Gardasil, including fainting and dizziness. But a potentially far more dangerous risk is the growing incidence of intussusception among children who use Merck's vaccine Rotateq. Intussusception occurs when the intestine telescopes into itself, causing an obstruction of the bowel that is repaired surgically.

Almost a year after approving Rotateq to prevent gastrointestinal illnesses in children, the FDA has issued an advisory warning parents about the risk of intussusception (which was also the most common side effect associated with Wyeth's long-gone RotaShield that was pulled from the market in 1999). Although no deaths due to Rotateq have been reported so far, 16 of the 28 reported cases required surgery to repair a baby's intestinal tract. As so many times over the last century, how many lie dormant until later detection?

USA Today February 21, 2007

Read Merck's "Help Pay for Vioxx" Mandatory Vaccine Campaign February 8, 2007

LENA'S COMMENT: As states line up behind all the push for vaccinating young girls the sad news comes out but nobody is listening! This is a disaster for those girls later in life!

'Don't Discuss Polar Bears' - US Memo to Scientists
March 12, 2007

WASHINGTON - Polar bears, sea ice and global warming are taboo subjects, at least in public, for some US scientists attending meetings abroad, environmental groups and a top federal wildlife official said on Thursday.

Environmental activists called this scientific censorship, which they said was in line with the Bush administration's history of muzzling dissent over global climate change.

But H. Dale Hall, director of the US Fish and Wildlife Service, said this policy was a long-standing one, meant to honor international protocols for meetings where the topics of discussion are negotiated in advance.

The matter came to light in e-mails from the Fish and Wildlife Service that were distributed by the Natural Resources Defense Council and the Center for Biological Diversity, both environmental groups.

Listed as a "new requirement" for foreign travelers on US government business, the memo says that requests for foreign travel "involving or potentially involving climate change, sea ice, and/or polar bears" require special handling, including notice of who will be the official spokesman for the trip.

The Fish and Wildlife Service top officials need assurance that the spokesman, "the one responding to questions on these issues, particularly polar bears" understands the administration's position on these topics.

Two accompanying memos were offered as examples of these kinds of assurance. Both included the line that the traveler "understands the administration's position on climate change, polar bears, and sea ice and will not be speaking on or responding to these issues."

ARE POLAR BEARS 'THREATENED'?

Polar bears are a hot topic for the Bush administration, which decided in December to consider whether to list the white-furred behemoths as "threatened" under the Endangered Species Act, because of scientific reports that the bears' icy habitat is melting due to global warming.

Hall said a decision is expected in January 2008. A "threatened" listing would bar the government from taking any action that jeopardizes the animal's existence, and might spur debate about tougher measures to cut the greenhouse gas emissions that spur global warming.

Hall defended the policy laid out in the memos, saying it was meant to keep scientists from straying from a set agenda at meetings in countries like Russia, Norway and Canada.

For example, he said, one meeting was about "human and polar bear interface." Receding Arctic sea ice where polar bears live and the global climate change that likely played a role in the melting were not proper discussion topics, he said.

"That's not a climate change discussion," Hall said at a telephone briefing. "That's a management, on-the-ground type discussion."

The prohibition on talking about these subjects only applies to public, formal situations, Hall said. Private scientific discussions outside the meeting and away from media are permitted and encouraged, he said.

"This administration has a long history of censoring speech and science on global warming," Eben Burnham-Snyder of the Natural Resources Defense Council said by telephone.

"Whenever we see an instance of the Bush administration restricting speech on global warming, it sends up a huge red flag that their commitment to the issue does not reflect their rhetoric," Burnham-Snyder said.

Story by Deborah Zabarenko, Environment Correspondent

REUTERS NEWS SERVICE